Showing results (61-70 of 105) with videos related to
Sort By:
Pageof 11
Experimental Brain Research|January 1, 1987
The primate nucleus basalis of Meynert: neuronal activity related to a visuomotor tracking taskS J Mitchell, R T Richardson, F H Baker, et al.Brain Research Bulletin|September 1, 1985
Noncollateral projections of basal forebrain neurons to frontal and parietal neocortex in primatesL C Walker, C A Kitt, M R DeLong, et al.Neurology|July 1, 1997
Tactile spatial acuity and roughness discrimination: impairments due to aging and Parkinson's diseaseK Sathian, A Zangaladze, J Green, et al.Wiener Klinische Wochenschrift|July 19, 1985
[Behavior of HDL cholesterol and the apoproteins A1 A2 and B in the central circulation in patients with coronary disease and genetically determined hyperlipoproteinemias]T Wichmann, D Grafnetter, E Meyer, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|September 1, 1988
Acetylcholine release in rat nucleus accumbens is regulated through dopamine D2-receptorsK Wedzony, N Limberger, L Späth, et al.Zeitschrift Fur Die Gesamte Innere Medizin Und Ihre Grenzgebiete|March 1, 1983
[Behavior of important serum lipid fractions in chronic hemodialysis patients and following kidney transplantation]V Luci, T Wichmann, M Giesselmann, et al.Wiener Klinische Wochenschrift|September 23, 1988
[Scanning electron microscopy studies in the detection of apo-B,E receptor activity of the lymphocyte membrane for diagnostic verification of genetically determined disorders of lipid metabolism]C Gläser, T Wichmann, U Wagner, et al.Journal of Neurosurgery|October 3, 2000
Electrophysiological localization of the substantia nigra in the parkinsonian nonhuman primateP A Starr, T Subramanian, R A Bakay, et al.Cell Transplantation|May 25, 1999
Intranigral transplantation of fetal substantia nigra allograft in the hemiparkinsonian rhesus monkeyP A Starr, T Wichmann, C van Horne, et al.Zeitschrift Fur Die Gesamte Innere Medizin Und Ihre Grenzgebiete|June 15, 1982
[Lipid chemical parameters and incidence of genetically determined hyperlipoproteinemias in patients between 20 and 45 years of age with coronary heart disease]T Wichmann, H A Freye, E Meyer, et al.Pageof 11